Business

The market will bring billions to the cannabis industry in 2020

Cannabis companies continue to invest more and more in their growth, even across borders, but they were unable to turn their investments into profits and suffered heavy losses. Neither Aurora Cannabis nor Canopy Growth was able to meet analysts' expectations. But, according to Barclays analysts, the Canadian cannabis market could be worth $28 billion in the spring of 2020.

A real cannabis boom started two years ago thanks to the legalization of cannabis in Canada and in the U.S. Investors believe that the cannabis industry in 2020 will gain a large profit.

In 2018, Canopy Growth, Aurora Cannabis, Tilray, Cronos, and HEXO and Co. became the favorite companies of investors.

But in the course of this year, the negative headlines in the cannabis industry increased and some companies remained below expectations with their figures.

Hemp.im is a mobile application that is exclusively dedicated to hemp, marijuana investing, and the cannabis industry. The app covers topics like the latest changes in regulations, cannabis legalization, health benefits of hemp, and products that are made from hemp.

An optimistic start for the cannabis industry in 2020

At the beginning of the year, the development of cannabis stocks for 2019 seemed to have only one direction: upwards. Stock market expert Jim Cramer called the Canopy Growth stock the best in the cannabis market.

In just one month, the share price rose by more than 80% and analysts even believed it could do more. Vivien Azer, considered to be the top analyst in the industry, has a positive feeling for 2019.

Many mergers coming up in the market

According to experts, there remains some optimism for the next year in the cannabis industry. (Source)

2019 was the year of big deals on the cannabis market. The hype surrounding cannabis and its ingredients, such as CBD, led to the formation of many new companies.

But smaller companies would not have been able to withstand the competition on their own, which made mergers important in order to assert themselves on the market.

At the beginning of the year, the major players had already begun to buy up smaller companies and this trend will continue. In the spring, for example, Cresco Labs bought Origin House for more than $753 billion (CA$1 billion).

But deals were not only made at this level. Some large Canadian cannabis companies did business with large companies from other industries. Canopy Growth dealt with the beverage producer Constellation Brands or Cronos with the Marlboro producer Altria.

What will happen to the cannabis industry in 2020?

Because cannabis is still illegal at the federal level in the U.S., but individual states may enact laws that differ from this law, there is a patchwork of regulations in the U.S.

In some countries, cannabis has been fully legalized. In others, cannabis is only allowed for medical purposes.

However, in some countries cannabis is still illegal. While possession of small quantities is only punishable as a minor offense in certain countries, it is punishable by imprisonment in others.

The future of the cannabis market is associated with its legal status in the United States. (Source)

Further developments in the U.S. legalization issue will be crucial for the future of the cannabis market.

Should Washington, Oregon, Nevada, California, Colorado, Alaska, Michigan, Maine, Vermont, and Massachusetts be followed by other states that legalize the cultivation, sale, and consumption of cannabis, this could support the industry again.

This is because the cannabis market in the U.S., according to Barclays analysts, would already have been worth $28 billion at that time in spring. Had the legalization been enforced, by 2028, it could already be worth around $41 billion.

In any case, the U.S., “with one-third of global demand,” is the largest cannabis market in the world, as the analyst, Garrett Nelson of the market analysis institute CFRA quoted.

__

(Featured image by MichaelGaida via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in finanzen.at, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Andrew Ross

Andrew Ross is a features writer whose stories are centered on emerging economies and fast-growing companies. His articles often look at trade policies and practices, geopolitics, mining and commodities, as well as the exciting world of technology. He also covers industries that have piqued the interest of the stock market, such as cryptocurrency and cannabis. He is a certified gadget enthusiast.

Recent Posts

DEA Hearing on Cannabis Reclassification in the United States Postponed to 2025

The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…

59 mins ago

California Opens Debate on Cannabis Potency With New Report

A new California Department of Public Health report has come out with recommendations for THC…

1 day ago

Ontario Increases Efforts to Combat Illegal Cannabis Market

Ontario is investing $31 million over the next three years to enhance efforts against illegal…

5 days ago

Hanover and Frankfurt Will Be the First German Cities to Legally Sell Cannabis for Adult Use

Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…

6 days ago

CBD Decree Suspended By Italian Administrative Court for Third Time

Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…

1 week ago

Which U.S. States Will Vote on Cannabis Legalization in November 2024?

This November, five U.S. states will vote on measures related to legalizing recreational or medical…

2 weeks ago